- Home
- CNTB vs PDSB Comparison
CNTB vs PDSB Comparison
Compare CNTB & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- PDSB
- Stock Information
- Founded
- CNTB 2012
- PDSB 2005
- Country
- CNTB United States
- PDSB United States
- Employees
- CNTB N/A
- PDSB N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- CNTB Health Care
- PDSB Health Care
- Exchange
- CNTB Nasdaq
- PDSB Nasdaq
- Market Cap
- CNTB 55.2M
- PDSB 58.7M
- IPO Year
- CNTB 2021
- PDSB N/A
- Fundamental
- Price
- CNTB $0.87
- PDSB $1.34
- Analyst Decision
- CNTB Strong Buy
- PDSB Strong Buy
- Analyst Count
- CNTB 1
- PDSB 3
- Target Price
- CNTB $8.00
- PDSB $14.00
- AVG Volume (30 Days)
- CNTB 22.8K
- PDSB 235.1K
- Earning Date
- CNTB 04-15-2025
- PDSB 03-26-2025
- Dividend Yield
- CNTB N/A
- PDSB N/A
- EPS Growth
- CNTB N/A
- PDSB N/A
- EPS
- CNTB N/A
- PDSB N/A
- Revenue
- CNTB $24,116,000.00
- PDSB N/A
- Revenue This Year
- CNTB N/A
- PDSB N/A
- Revenue Next Year
- CNTB $63.90
- PDSB N/A
- P/E Ratio
- CNTB N/A
- PDSB N/A
- Revenue Growth
- CNTB N/A
- PDSB N/A
- 52 Week Low
- CNTB $0.77
- PDSB $1.25
- 52 Week High
- CNTB $2.66
- PDSB $6.68
- Technical
- Relative Strength Index (RSI)
- CNTB 37.85
- PDSB 40.27
- Support Level
- CNTB $0.91
- PDSB $1.41
- Resistance Level
- CNTB $0.95
- PDSB $1.56
- Average True Range (ATR)
- CNTB 0.08
- PDSB 0.14
- MACD
- CNTB -0.01
- PDSB -0.00
- Stochastic Oscillator
- CNTB 27.95
- PDSB 21.24
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.